Analyst Price Targets — LONA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 19, 2026 10:40 am | Graig Suvannavejh | Mizuho Securities | $15.00 | $8.17 | StreetInsider | LeonaBio (LONA) PT Lowered to $15 at Mizuho |
| May 27, 2026 7:46 am | Kelsey Goodwin | Piper Sandler | $20.00 | $9.67 | StreetInsider | Piper Sandler Starts LeonaBio (LONA) at Overweight |
| February 18, 2026 9:40 pm | — | Mizuho Securities | $10.00 | $4.76 | TheFly | LeonaBio upgraded to Outperform from Neutral at Mizuho |
| September 19, 2025 11:02 am | Graig Suvannavejh | Mizuho Securities | $4.00 | $3.83 | TheFly | Athira Pharma price target lowered to $4 from $5 at Mizuho |
| June 22, 2022 6:52 pm | Andrew Tsai | Jefferies | $3.00 | $2.85 | TheFly | Athira Pharma downgraded to Hold from Buy at Jefferies |
| April 21, 2022 8:46 am | — | Berenberg Bank | $33.00 | $11.63 | Benzinga | Berenberg Initiates Coverage On Athira Pharma with Buy Rating, Announces Price Target of $33 |
Latest News for LONA
BOTHELL, Wash., Sept. 03, 2026 (GLOBE NEWSWIRE) -- LeonaBio, Inc. (NASDAQ: LONA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, today announced that Company management will participate in the Cantor Global Healthcare Conference 2026, taking place September 9-11, 2026 in New York, NY.
On Track to Complete Enrollment of Phase 3 ELAINE-3 Clinical Trial of Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer in 4Q 2026 with Topline Data Expected in 2H 2027
BOTHELL, Wash., Aug. 12, 2026 (GLOBE NEWSWIRE) -- LeonaBio, Inc. (NASDAQ: LONA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, today announced that its lead product candidate, lasofoxifene, will be featured in multiple presentations at Dava Oncology's 4th Summit on Breast Cancer taking place from August 18-22, 2026, in Kona,…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for LONA.
U.S. House Trading
No House trades found for LONA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.